The Latest Breaking News from Vitruvias

Vitruvias Therapeutics thyroid tablet recall: FDA issues serious Class I warning over ‘superpotent’ medicine — check lot number, expiration date and what patients should know

Vitruvias Therapeutics thyroid tablet recall: The FDA has issued a serious Class I recall for one lot of Vitruvias Therapeutics thyroid tablets after the medicine was found to be potentially “superpotent.” The recalled Thyroid Tablets, USP 30 mg may contain more thyroid hormone than intended, raising concerns about serious health…

The Economic Times · Sep 24

Vitruvias Therapeutics Thyroid Tablet Recall: 'Superpotent' Pills Risk Elderly and Pregnant Patients

Vitruvias Therapeutics recalls 30 mg thyroid tablets nationwide over superpotency risks to elderly and pregnant patients. Learn more about the recall and safety steps.

International Business Times UK · Aug 26